Cancer-related fatigue: guidelines for evaluation and management.

Area of Science:

• Oncology
• Palliative Care
• Quality of Life Research

Background:

• Cancer-related fatigue is a widespread and debilitating symptom affecting patients' physical, psychological, and social functioning.
• Despite its prevalence and impact, cancer-related fatigue is frequently underdiagnosed and undertreated in clinical practice.
• Cancer-related fatigue is now recognized in the International Classification of Diseases 10th Revision-Clinical Modification, highlighting its clinical significance.

Discussion:

• Effective fatigue management requires a thorough assessment beyond mere severity, encompassing characteristics, impact on daily activities, and identification of underlying causes.
• Potential causes include the primary cancer, treatments, co-existing medical conditions, and psychological factors.
• Interventions range from drug regimen adjustments and metabolic correction to pharmacologic treatments for anemia, depression, and insomnia.

Key Insights:

• Multifaceted interventions are available, including exercise, cognitive therapies, sleep hygiene, nutritional support, and pharmacologic agents like psychostimulants and corticosteroids.
• Early and routine assessment of fatigue is essential for timely intervention and improved patient outcomes.
• Addressing fatigue is critical for enhancing the overall quality of life for cancer patients and their caregivers.

Outlook:

• Further research is necessary to fully elucidate the complex etiologies of cancer-related fatigue and refine treatment strategies.
• Integration of standardized fatigue assessment tools into routine oncology care is recommended.
• Personalized treatment plans tailored to individual patient needs and fatigue profiles hold promise for optimizing care.